SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration

Author:

Sasaki Yo1ORCID,Kakita Hiroki12,Kubota Shunsuke3,Sene Abdoulaye3,Lee Tae Jun3ORCID,Ban Norimitsu3,Dong Zhenyu3,Lin Joseph B3ORCID,Boye Sanford L4ORCID,DiAntonio Aaron56ORCID,Boye Shannon E7ORCID,Apte Rajendra S358ORCID,Milbrandt Jeffrey16

Affiliation:

1. Department of Genetics, Washington University School of Medicine, St. Louis, United States

2. Department of Perinatal and Neonatal Medicine, Aichi Medical University, Aichi, Japan

3. Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, United States

4. Department of Pediatrics, Powell Gene Therapy Center, Gainesville, United States

5. Department of Developmental Biology, Washington University School of Medicine, St. Louis, United States

6. Needleman Center for Neurometabolism and Axonal Therapeutics, St. Louis, United States

7. Department of Pediatrics, Division of Cellular and Molecular Therapy, Gainesville, United States

8. Department of Medicine, Washington University School of Medicine, St. Louis, United States

Abstract

Leber congenital amaurosis type nine is an autosomal recessive retinopathy caused by mutations of the NAD+ synthesis enzyme NMNAT1. Despite the ubiquitous expression of NMNAT1, patients do not manifest pathologies other than retinal degeneration. Here we demonstrate that widespread NMNAT1 depletion in adult mice mirrors the human pathology, with selective loss of photoreceptors highlighting the exquisite vulnerability of these cells to NMNAT1 loss. Conditional deletion demonstrates that NMNAT1 is required within the photoreceptor. Mechanistically, loss of NMNAT1 activates the NADase SARM1, the central executioner of axon degeneration, to trigger photoreceptor death and vision loss. Hence, the essential function of NMNAT1 in photoreceptors is to inhibit SARM1, highlighting an unexpected shared mechanism between axonal degeneration and photoreceptor neurodegeneration. These results define a novel SARM1-dependent photoreceptor cell death pathway and identifies SARM1 as a therapeutic candidate for retinopathies.

Funder

National Institute on Aging

National Institute of Neurological Disorders and Stroke

National Cancer Institute

National Eye Institute

The Needleman Center for Neurometabolism and Axonal therapeutics

Edward N. & Della L. Thome Memorial Foundation

Carl and Mildred Almen Reeves Foundation

Starr Foundation

Bill and Emily Kuzma Family Gift for Retinal Research

Jeffrey Fort Innovation Fund

Glenn Foundation for Medical Research

Research to Prevent Blindness, Inc

Washington University in St. Louis Medical Scientist Training Program (NIH).

Research to Prevent Blindness Nelson Trust Award

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3